Melasma: Update on management

Amanda K. Suggs, Selina S. Hamill, Paul M. Friedman

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Melasma is a common, acquired, chronic cutaneous pigment disorder that is often difficult to treat and has a high recurrence rate. The goal of a melasma treatment regimen is to decrease pigment production and increase elimination. Topical tyrosinase inhibitors block melanin synthesis and thereby reduce pigment production. Peels and laser- and light-based devices increase melanin elimination. A multimodality treatment approach targeting both pigment production and elimination is necessary to achieve equilibrium and disease remission. Maintenance treatments are often necessary due to the high recurrence rate. Strict photoprotection is critical to prevent melanogenesis and rebound. Targeting the vasculature via pulsed dye laser or tranexamic acid is another approach to treatment.

Original languageEnglish (US)
Pages (from-to)217-225
Number of pages9
JournalSeminars in cutaneous medicine and surgery
Volume37
Issue number4
DOIs
StatePublished - Dec 1 2018

ASJC Scopus subject areas

  • Surgery
  • Dermatology

Fingerprint Dive into the research topics of 'Melasma: Update on management'. Together they form a unique fingerprint.

Cite this